tiprankstipranks
Trending News
More News >
OncoZenge AB (DE:8LY)
FRANKFURT:8LY
Germany Market

OncoZenge AB (8LY) Income Statement

Compare
0 Followers

OncoZenge AB Income Statement

Last quarter (Q4 2025), OncoZenge AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, OncoZenge AB's net income was kr-9.89M. See OncoZenge AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 2.66Mkr 1.00Kkr 3.00Kkr 0.00kr 0.00
Gross Profit
kr -4.84Mkr 1.00Kkr 3.00Kkr 0.00kr 0.00
Operating Expenses
kr 11.03Mkr 8.69Mkr 15.90Mkr 43.57Mkr 4.89M
Depreciation and Amortization
kr 0.00kr 0.00kr 23.17Mkr 23.17Mkr 0.00
EBITDA
kr -15.87Mkr -8.69Mkr 7.27Mkr 2.77Mkr -4.89M
Operating Income
kr -15.87Mkr -8.69Mkr -15.90Mkr -43.57Mkr -4.89M
Other Income/Expenses
kr -70.00Kkr -3.00Kkr 0.00kr 0.00kr 0.00
Pretax Income
kr -15.94Mkr -8.69Mkr -15.90Mkr -43.57Mkr -4.89M
Net Income
kr -15.94Mkr -8.69Mkr -15.90Mkr -46.65Mkr -3.89M
Per Share Metrics
Basic EPS
kr -1.31kr -0.74kr -1.36kr -3.98kr -0.33
Diluted EPS
kr -1.31kr -0.74kr -1.36kr -3.98kr -0.33
Weighted Average Shares Outstanding
12.13M 11.71M 11.71M 11.71M 11.71M
Weighted Average Shares Outstanding (Diluted)
12.13M 11.71M 11.71M 11.71M 11.71M
Currency in SEK

OncoZenge AB Earnings and Revenue History